Stage IV Colon Cancer AJCC v7
4 clinical trials · Condition
◉ Watch Stage IV Colon Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer (NCT04294264) | Rutgers, The State University of New Jersey | 2019-02-12 |
| Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery (NCT03317119) | City of Hope Medical Center | 2018-04-11 |
| S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882) | SWOG Cancer Research Network | 2017-11-27 |
| Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (NCT02381561) | National Cancer Institute (NCI) | 2016-02-01 |
Track Stage IV Colon Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.